Literature DB >> 17116761

Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events?

Alfredo M Germain1, Mary Carmen Romanik, Irene Guerra, Sandra Solari, María Soledad Reyes, Richard J Johnson, Karen Price, S Ananth Karumanchi, Gloria Valdés.   

Abstract

We tested the hypothesis that endothelial dysfunction could cause placentation-related defects, persist after the complicated pregnancy, and probably cause cardiovascular disease later in life. Brachial arterial reactivity and factors related to endothelial dysfunction, such as circulating cholesterol, uric acid, nitrites, l-arginine, asymmetrical dimethylarginine, vascular endothelial growth factor, and soluble vascular endothelial growth factor receptor-1, in women with previous healthy pregnancies (n=22), patients with severe preeclampsia (n=25), or patients with recurrent pregnancy loss (n=29), at day 10 of the luteal phase of an ovulatory cycle an average of 11 to 27 months after pregnancy were evaluated. Both groups with placentation defects had a significant decrease in endothelium-dependent dilatation, a higher rate of endothelial dysfunction, lower serum nitrites, and higher cholesterol as compared with control subjects; subjects with previous preeclampsia additionally had higher normal blood pressures and a greater parental prevalence of cardiovascular disease. Patients with recurrent pregnancy loss also demonstrated a significantly lower endothelium-independent vasodilatation. A trend to an inverse correlation was found between serum cholesterol serum and endothelial-mediated vasodilatation in the whole study population. Uric acid, l-arginine, asymmetrical dimethylarginine, vascular endothelial growth factor, and soluble vascular endothelial growth factor receptor-1 were similar in all of the groups. We postulate that endothelial dysfunction may represent a link between preeclampsia and increased cardiovascular disease latter in life and propose that women with unexplained recurrent miscarriages are also at increased cardiovascular risk. The identification and correction of endothelial dysfunction detected during the reproductive stage on obstetric outcome and on cardiovascular diseases needs to be elucidated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17116761     DOI: 10.1161/01.HYP.0000251522.18094.d4

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  71 in total

1.  IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate?

Authors:  Babbette Lamarca; Justin Brewer; Kedra Wallace
Journal:  Int J Interferon Cytokine Mediat Res       Date:  2011-07-01

2.  Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia.

Authors:  B Lamarca
Journal:  Minerva Ginecol       Date:  2012-08

3.  The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia.

Authors:  B Lamarca
Journal:  Minerva Ginecol       Date:  2010-04

Review 4.  Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia.

Authors:  Babbette D LaMarca; Jeffery Gilbert; Joey P Granger
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

5.  Risk of cardiovascular disease among postmenopausal women with prior pregnancy loss: the women's health initiative.

Authors:  Donna R Parker; Bing Lu; Megan Sands-Lincoln; Candyce H Kroenke; Cathy C Lee; Mary O'Sullivan; Hannah L Park; Nisha Parikh; Robert S Schenken; Charles B Eaton
Journal:  Ann Fam Med       Date:  2014-07       Impact factor: 5.166

6.  Effects of maternal serum on permeability of glomerular endothelial cell membrane.

Authors:  Hui Du; Haiyi Liu; Jun Zhao; Yuanyuan Wu; Xun Gong; Qiong Zhou; Jingjing Xu; Yuqi Li; Xinwei Shi; Fuyuan Qiao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-02-19

Review 7.  How does preeclampsia predispose to future cardiovascular disease?

Authors:  Dawn C Scantlebury; Sharonne N Hayes
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

8.  The two stage model of preeclampsia: variations on the theme.

Authors:  J M Roberts; C A Hubel
Journal:  Placenta       Date:  2008-12-13       Impact factor: 3.481

9.  Association between history of abortion and metabolic syndrome in middle-aged and elderly Chinese women.

Authors:  Baihui Xu; Jie Zhang; Yu Xu; Jieli Lu; Min Xu; Yuhong Chen; Yufang Bi; Guang Ning
Journal:  Front Med       Date:  2013-02-06       Impact factor: 4.592

10.  Ambient air pollution and risk of pregnancy loss among women undergoing assisted reproduction.

Authors:  Audrey J Gaskins; Lidia Mínguez-Alarcón; Paige L Williams; Jorge E Chavarro; Joel D Schwartz; Itai Kloog; Irene Souter; Russ Hauser; Francine Laden
Journal:  Environ Res       Date:  2020-09-13       Impact factor: 6.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.